Wade JD - Search Results

1

Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity.

Beccari S, Kovalszky I, Wade JD, Otvos L Jr, Surmacz E. Beccari S, et al. Among authors: wade jd. Peptides. 2013 Jun;44:127-34. doi: 10.1016/j.peptides.2013.03.027. Epub 2013 Apr 6. Peptides. 2013. PMID: 23567149

2

Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis.

Otvos L Jr, Shao WH, Vanniasinghe AS, Amon MA, Holub MC, Kovalszky I, Wade JD, Doll M, Cohen PL, Manolios N, Surmacz E. Otvos L Jr, et al. Among authors: wade jd. Peptides. 2011 Aug;32(8):1567-74. doi: 10.1016/j.peptides.2011.06.015. Epub 2011 Jun 23. Peptides. 2011. PMID: 21723351

3

Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin.

Hossain MA, Wade JD, Bathgate RA. Hossain MA, et al. Among authors: wade jd. Peptides. 2012 May;35(1):102-6. doi: 10.1016/j.peptides.2012.02.021. Epub 2012 Mar 5. Peptides. 2012. PMID: 22414484

4

Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics.

Cassone M, Vogiatzi P, La Montagna R, De Olivier Inacio V, Cudic P, Wade JD, Otvos L Jr. Cassone M, et al. Among authors: wade jd. Peptides. 2008 Nov;29(11):1878-86. doi: 10.1016/j.peptides.2008.07.016. Epub 2008 Aug 5. Peptides. 2008. PMID: 18721837

5

Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo.

Noto PB, Abbadessa G, Cassone M, Mateo GD, Agelan A, Wade JD, Szabo D, Kocsis B, Nagy K, Rozgonyi F, Otvos L Jr. Noto PB, et al. Among authors: wade jd. Protein Sci. 2008 Jul;17(7):1249-55. doi: 10.1110/ps.034330.108. Epub 2008 Apr 15. Protein Sci. 2008. PMID: 18413862 Free PMC article.

6

Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling.

Otvos L Jr, Kovalszky I, Olah J, Coroniti R, Knappe D, Nollmann FI, Hoffmann R, Wade JD, Lovas S, Surmacz E. Otvos L Jr, et al. Among authors: wade jd. Biopolymers. 2015 May;104(3):156-66. doi: 10.1002/bip.22627. Biopolymers. 2015. PMID: 25683126

7

The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor.

Otvos L Jr, Vetter SW, Koladia M, Knappe D, Schmidt R, Ostorhazi E, Kovalszky I, Bionda N, Cudic P, Surmacz E, Wade JD, Hoffmann R. Otvos L Jr, et al. Among authors: wade jd. Amino Acids. 2014 Apr;46(4):873-82. doi: 10.1007/s00726-013-1650-6. Epub 2013 Dec 24. Amino Acids. 2014. PMID: 24366600

8

The designer proline-rich antibacterial peptide A3-APO prevents Bacillus anthracis mortality by deactivating bacterial toxins.

Otvos L Jr, Flick-Smith H, Fox M, Ostorhazi E, Dawson RM, Wade JD. Otvos L Jr, et al. Among authors: wade jd. Protein Pept Lett. 2014 Apr;21(4):374-81. doi: 10.2174/09298665113206660108. Protein Pept Lett. 2014. PMID: 24164262

9

Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer.

Otvos L Jr, Kovalszky I, Riolfi M, Ferla R, Olah J, Sztodola A, Nama K, Molino A, Piubello Q, Wade JD, Surmacz E. Otvos L Jr, et al. Among authors: wade jd. Eur J Cancer. 2011 Jul;47(10):1578-84. doi: 10.1016/j.ejca.2011.01.018. Epub 2011 Feb 23. Eur J Cancer. 2011. PMID: 21353530

10

Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation.

Otvos L Jr, Kovalszky I, Scolaro L, Sztodola A, Olah J, Cassone M, Knappe D, Hoffmann R, Lovas S, Hatfield MP, Beko G, Zhang S, Wade JD, Surmacz E. Otvos L Jr, et al. Among authors: wade jd. Biopolymers. 2011;96(2):117-25. doi: 10.1002/bip.21377. Biopolymers. 2011. PMID: 20564005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results